HTR1A binds HTR1A antagonists (Q112999068)

An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-9648268)

Language	Label	Description	Also known as
English	HTR1A binds HTR1A antagonists	An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-9648268)

Statements

instance of

1 reference

8 July 2022

1 reference

8 July 2022

1 reference

8 July 2022

https://identifiers.org/reactome:R-HSA-9648268

1 reference

8 July 2022

5-hydroxytryptamine receptor 1A

quantity

1

object of statement has role

1 reference

8 July 2022

HTR1A antagonists [extracellular region]

quantity

1

object of statement has role

1 reference

8 July 2022

HTR1A:HTR1A Antagonist drugs [plasma membrane]

quantity

1

object of statement has role

1 reference

8 July 2022

Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a [35S]GTPgammaS binding study

1 reference

8 July 2022

New insight into the therapeutic role of 5-HT1A receptors in central nervous system disorders

1 reference

8 July 2022

Agonist activity of antimigraine drugs at recombinant human 5-HT1A receptors: potential implications for prophylactic and acute therapy

1 reference

8 July 2022

S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in compar

1 reference

8 July 2022

Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.

1 reference

8 July 2022

[11C]-WAY100635 PET demonstrates marked 5-HT1A receptor changes in sporadic ALS.

1 reference

8 July 2022

2-Substituted tryptamines: agents with selectivity for 5-HT(6) serotonin receptors

1 reference

8 July 2022

Ligand binding characteristics of the human serotonin1A receptor heterologously expressed in CHO cells.

1 reference

8 July 2022

Characterization of the aminomethylchroman derivative BAY x 3702 as a highly potent 5-hydroxytryptamine1A receptor agonist

1 reference

8 July 2022

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1 reference

8 July 2022

A 18F-MPPF PET normative database of 5-HT1A receptor binding in men and women over aging

1 reference

8 July 2022

Pharmacological characterization of recombinant human 5-hydroxytryptamine1A receptors using a novel antagonist radioligand, [3H]WAY-100635.

1 reference

8 July 2022

Synthesis, receptor binding and functional studies of mesoridazine stereoisomers

1 reference

8 July 2022

High-level stable expression of recombinant 5-HT1A 5-hydroxytryptamine receptors in Chinese hamster ovary cells

1 reference

8 July 2022

The in vitro pharmacology of the beta-adrenergic receptor pet ligand (s)-fluorocarazolol reveals high affinity for cloned beta-adrenergic receptors and moderate affinity for the human 5-HT1A receptor

1 reference

8 July 2022

SB-272183, a selective 5-HT(1A), 5-HT(1B) and 5-HT(1D) receptor antagonist in native tissue

1 reference

8 July 2022

Discovery of the first potent, selective 5-hydroxytryptamine1D receptor antagonist.

1 reference

8 July 2022

Receptor binding characteristics of [3H]NAD-299, a new selective 5-HT1A receptor antagonist

1 reference

8 July 2022

The pharmacological characterization of a novel selective 5-hydroxytryptamine1A receptor antagonist, NAD-299.

1 reference

8 July 2022

Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders

1 reference

8 July 2022

N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-nitrophenyl) cyclohexanecarboxamide: a novel pre- and postsynaptic 5-hydroxytryptamine(1A) receptor antagonist active on the lower urinary tract

1 reference

8 July 2022

Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists

1 reference

8 July 2022

Affinity of cyamemazine, an anxiolytic antipsychotic drug, for human recombinant dopamine vs. serotonin receptor subtypes

1 reference

8 July 2022

1 reference

8 July 2022

Identifiers

1 reference

8 July 2022

HTR1A binds HTR1A antagonists (Q112999068)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

HTR1A binds HTR1A antagonists (Q112999068)

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Navigation menu

Search